Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT06620523

Prevent Cardiac Surgery Associated AKI Trial

Conditions: Renal Failure, Coronary Artery Disease, Surgery, Surgery-Complications

Sex: All

Ages: 18 Years – 70 Years

Healthy volunteers: No

Phase: PHASE2

Enrollment: 242

Sponsor: George Washington University

Location: George Washington University Hospital Washington D.C. District of Columbia

Summary

Prevent CSA-AKI (Cardiac Surgery Associated Acute Kidney Injury) trial is a double blinded randomized controlled trial, 242 patients undergoing elective cardiopulmonary bypass surgery (CPB)will either receive a placebo or daily 1200 mg of Co enzyme Q10 (CoQ10) and 1000 mg of Glutathione (GSH), the first dose will be given the day before surgery and continues while admitted up to 1 week. Blood and urine samples will be collected. Adverse events related to the study drugs will be collected.

Eligibility Criteria

Inclusion Criteria: * Adult 18-70 years of age * Undergoing elective CPB (Cardiopulmonary Bypass) surgery * Baseline GFR (Glomerular Filtration Rate) ≥45 ml/min Exclusion Criteria: * GFR (Glomerular Filtration Rate) \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06620523). StuddyBuddy aggregates publicly available trial information.